These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 39237642)

  • 21. Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders.
    Komulainen-Ebrahim J; Schreiber JM; Kangas SM; Pylkäs K; Suo-Palosaari M; Rahikkala E; Liinamaa J; Immonen EV; Hassinen I; Myllynen P; Rantala H; Hinttala R; Uusimaa J
    Seizure; 2019 Jul; 69():99-104. PubMed ID: 31004928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental and epileptic encephalopathies: what we do and do not know.
    Specchio N; Curatolo P
    Brain; 2021 Feb; 144(1):32-43. PubMed ID: 33279965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rett Syndrome Spectrum in Monogenic Developmental-Epileptic Encephalopathies and Epilepsies: A Review.
    Spagnoli C; Fusco C; Pisani F
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric-Onset Epilepsy and Developmental Epileptic Encephalopathies Followed by Early-Onset Parkinsonism.
    Spagnoli C; Fusco C; Pisani F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of clinical and physiologic aspects of status epilepticus in the developmental and epileptic encephalopathies.
    Wirrell EC
    Epilepsy Behav; 2024 Oct; 159():109950. PubMed ID: 39067356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights.
    Ng AC; Chahine M; Scantlebury MH; Appendino JP
    J Neurol; 2024 Jun; 271(6):3063-3094. PubMed ID: 38607431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCN1A-related phenotypes: Epilepsy and beyond.
    Scheffer IE; Nabbout R
    Epilepsia; 2019 Dec; 60 Suppl 3():S17-S24. PubMed ID: 31904117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of developmental and epileptic encephalopathies.
    Van Bogaert P
    Rev Neurol (Paris); 2022 Sep; 178(7):659-665. PubMed ID: 35489823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spectrum of SCN1A-related infantile epileptic encephalopathies.
    Harkin LA; McMahon JM; Iona X; Dibbens L; Pelekanos JT; Zuberi SM; Sadleir LG; Andermann E; Gill D; Farrell K; Connolly M; Stanley T; Harbord M; Andermann F; Wang J; Batish SD; Jones JG; Seltzer WK; Gardner A; ; Sutherland G; Berkovic SF; Mulley JC; Scheffer IE
    Brain; 2007 Mar; 130(Pt 3):843-52. PubMed ID: 17347258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances toward precision therapeutics for developmental and epileptic encephalopathies.
    Bertocchi I; Cambiaghi M; Hasan MT
    Front Neurosci; 2023; 17():1140679. PubMed ID: 37090807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myoclonus and epilepsies in children].
    Fejerman N
    Rev Neurol (Paris); 1991; 147(12):782-97. PubMed ID: 1780607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy.
    Goodspeed K; Liu JS; Nye KL; Prasad S; Sadhu C; Tavakkoli F; Bilder DA; Minassian BA; Bailey RM
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
    Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
    Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transition to adult life in the monogenic epilepsies.
    Scheffer IE; Dravet C
    Epilepsia; 2014 Aug; 55 Suppl 3():12-5. PubMed ID: 25209079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Genetic Testing to Precision Medicine in Epilepsy.
    Striano P; Minassian BA
    Neurotherapeutics; 2020 Apr; 17(2):609-615. PubMed ID: 31981099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
    Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
    Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes.
    Gardella E; Møller RS
    Epilepsia; 2019 Dec; 60 Suppl 3():S77-S85. PubMed ID: 31904124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Models for discovery of targeted therapy in genetic epileptic encephalopathies.
    Maljevic S; Reid CA; Petrou S
    J Neurochem; 2017 Oct; 143(1):30-48. PubMed ID: 28742937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel treatments in epilepsy guided by genetic diagnosis.
    Marini C; Giardino M
    Br J Clin Pharmacol; 2022 Jun; 88(6):2539-2551. PubMed ID: 34778987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies.
    Nicita F; De Liso P; Danti FR; Papetti L; Ursitti F; Castronovo A; Allemand F; Gennaro E; Zara F; Striano P; Spalice A
    Seizure; 2012 Jan; 21(1):3-11. PubMed ID: 21917483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.